β-Lactam Antibiotics Renaissance
AbstractSince the 1940s β-lactam antibiotics have been used to treat bacterial infections. However, emergence and dissemination of β-lactam resistance has reached the point where many marketed β-lactams no longer are clinically effective. The increasing prevalence of multidrug-resistant bacteria and the progressive withdrawal of pharmaceutical companies from antibiotic research have evoked a strong reaction from health authorities, who have implemented initiatives to encourage the discovery of new antibacterials. Despite this gloomy scenario, several novel β-lactam antibiotics and β-lactamase inhibitors have recently progressed into clinical trials, and many more such compounds are being investigated. Here we seek to provide highlights of recent developments relating to the discovery of novel β-lactam antibiotics and β-lactamase inhibitors. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Qin, W.; Panunzio, M.; Biondi, S. β-Lactam Antibiotics Renaissance. Antibiotics 2014, 3, 193-215.
Qin W, Panunzio M, Biondi S. β-Lactam Antibiotics Renaissance. Antibiotics. 2014; 3(2):193-215.Chicago/Turabian Style
Qin, Wenling; Panunzio, Mauro; Biondi, Stefano. 2014. "β-Lactam Antibiotics Renaissance." Antibiotics 3, no. 2: 193-215.